Mallick B N, Adya H V
School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Neurochem Int. 1999 Jun;34(6):499-507. doi: 10.1016/s0197-0186(99)00025-x.
It has been reported that norepinephrine increases Na-K ATPase activity by acting on alpha-1 adrenoceptors. The mechanism of such an increase was investigated. The norepinephrine induced increase in synaptosomal Na-K ATPase activity was prevented by pretreating the rat brain homogenate with either EDTA, a divalent cation chelator or prazosin, an alpha-1 adrenoceptor blocker. The norepinephrine and EGTA increased the Na-K ATPase activity in the synaptosome prepared from rat brain homogenate untreated with EDTA. The EGTA was ineffective in stimulating the enzyme activity if the synaptosome was prepared from homogenate treated with norepinephrine. However, the EGTA was effective in increasing the enzyme activity if the synaptosome was prepared from the homogenate treated with norepinephrine in the presence of prazosin. Thus, norepinephrine did not increase the Na-K ATPase activity in the presence of EDTA or alpha-1 adrenoceptor blocker. Similarly, the Ca++ chelator, EGTA, could not increase the enzyme activity if the homogenate was pretreated with norepinephrine alone. However, if norepinephrine action was blocked by alpha-1 antagonist prazosin, EGTA increased the enzyme activity possibly by chelation of Ca++. Further, chlorotetracycline fluorescence study showed that norepinephrine removes membrane bound Ca++. Thus, it is likely that norepinephrine acts on adrenoceptors and removes membrane bound Ca++ and thereby increases the Na-K ATPase activity in the synaptosome.
据报道,去甲肾上腺素通过作用于α-1肾上腺素能受体来增加钠钾ATP酶的活性。对这种增加的机制进行了研究。用二价阳离子螯合剂乙二胺四乙酸(EDTA)或α-1肾上腺素能受体阻滞剂哌唑嗪预处理大鼠脑匀浆,可阻止去甲肾上腺素诱导的突触体钠钾ATP酶活性增加。去甲肾上腺素和乙二醇双四乙酸(EGTA)增加了从未用EDTA处理的大鼠脑匀浆制备的突触体中的钠钾ATP酶活性。如果突触体是由用去甲肾上腺素处理过的匀浆制备的,EGTA对刺激酶活性无效。然而,如果突触体是由在哌唑嗪存在下用去甲肾上腺素处理过的匀浆制备的,EGTA对增加酶活性是有效的。因此,在存在EDTA或α-1肾上腺素能受体阻滞剂的情况下,去甲肾上腺素不会增加钠钾ATP酶活性。同样,如果仅用去甲肾上腺素预处理匀浆,钙离子螯合剂EGTA也不能增加酶活性。然而,如果用α-1拮抗剂哌唑嗪阻断去甲肾上腺素的作用,EGTA可能通过螯合钙离子来增加酶活性。此外,金霉素荧光研究表明,去甲肾上腺素会去除膜结合的钙离子。因此,去甲肾上腺素可能作用于肾上腺素能受体并去除膜结合的钙离子,从而增加突触体中的钠钾ATP酶活性。